No Cover Image

Journal article 21 views

Glucocorticoids in preterm human milk

Mariana Muelbert, Tanith Alexander, Mark H. Vickers, Jane E. Harding, Laura Galante Orcid Logo, Frank H. Bloomfield, (the DIAMOND study group)

Frontiers in Nutrition, Volume: 9

Swansea University Author: Laura Galante Orcid Logo

Full text not available from this repository: check for access using links below.

Abstract

Background: Glucocorticoids (GCs), cortisol and cortisone, are essential regulators of many physiological responses, including immunity, stress and mammary gland function. GCs are present in human milk (HM), but whether maternal and infant factors are associated with HM GC concentration following pr...

Full description

Published in: Frontiers in Nutrition
ISSN: 2296-861X
Published: Frontiers Media SA 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa68011
first_indexed 2025-01-09T20:32:22Z
last_indexed 2025-01-09T20:32:22Z
id cronfa68011
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2024-12-20T11:37:16.4950427</datestamp><bib-version>v2</bib-version><id>68011</id><entry>2024-10-18</entry><title>Glucocorticoids in preterm human milk</title><swanseaauthors><author><sid>d1c6c22f6a863ef2050ed9768566884b</sid><ORCID>0000-0002-6190-7955</ORCID><firstname>Laura</firstname><surname>Galante</surname><name>Laura Galante</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2024-10-18</date><deptcode>MEDS</deptcode><abstract>Background: Glucocorticoids (GCs), cortisol and cortisone, are essential regulators of many physiological responses, including immunity, stress and mammary gland function. GCs are present in human milk (HM), but whether maternal and infant factors are associated with HM GC concentration following preterm birth is unclear.Materials and methods: HM samples were collected on postnatal day 5 and 10 and at 4 months&#x2019; corrected age (4m CA) in a cohort of moderate- and late-preterm infants. GCs in HM were measured by liquid chromatography-tandem mass spectrometry. Relationships between GCs in HM and both maternal and infant characteristics were investigated using Spearman&#x2019;s correlations and linear mixed models.Results: 170 mothers of 191 infants provided 354 HM samples. Cortisol concentrations in HM increased from postnatal day 5&#x2013;4m CA (mean difference [MD] 0.6 &#xB1; 0.1 ng/ml, p &lt; 0.001). Cortisone concentration did not change across lactation but was higher than cortisol throughout. Compared to no antenatal corticosteroid (ANS), a complete course of ANS was associated with lower GC concentrations in HM through to 4m CA (cortisol: MD &#x2013;0.3 &#xB1; 0.1 ng/ml, p &lt; 0.01; cortisone MD &#x2013;1.8 &#xB1; 0.4 ng/ml, p &lt; 0.001). At 4m CA, higher maternal perceived stress was negatively associated with GC concentrations in HM (cortisol adjusted beta-coefficient [a&#x3B2;] &#x2013;0.01 &#xB1; 0.01 ng/ml, p = 0.05; and cortisone a&#x3B2; &#x2013;0.1 &#xB1; 0.03 ng/ml, p = 0.01), whereas higher postpartum depression and maternal obesity were associated with lower cortisone concentrations (a&#x3B2; &#x2013;0.1 &#xB1; 0.04 ng/ml p &lt; 0.05; MD [healthy versus obese] &#x2013;0.1 &#xB1; 0.04 ng/ml p &lt; 0.05, respectively). There was a weak positive correlation between GC concentrations in HM and gestational age at birth (r = 0.1, p &lt; 0.05). Infant birth head circumference z-score was negatively associated with cortisol concentrations (a&#x3B2; &#x2013;0.01 &#xB1; 0.04 ng/ml, p &lt; 0.05). At hospital discharge, fat-free mass showed a weak positive correlation with cortisol concentrations (r = 0.2, p = 0.03), while fat mass showed a weak negative correlation with cortisone concentrations (r = &#x2013;0.25, p &lt; 0.001).Conclusion: The mammary gland appears to protect the infant from cortisol through inactivation into cortisone. Maternal and infant characteristics were associated with concentration of GCs in HM, including ANS, stress and depression scores, obesity, gestational age and infant size. The effects of HM glucocorticoids on long-term health outcomes requires further research.</abstract><type>Journal Article</type><journal>Frontiers in Nutrition</journal><volume>9</volume><journalNumber/><paginationStart/><paginationEnd/><publisher>Frontiers Media SA</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>2296-861X</issnElectronic><keywords/><publishedDay>27</publishedDay><publishedMonth>9</publishedMonth><publishedYear>2022</publishedYear><publishedDate>2022-09-27</publishedDate><doi>10.3389/fnut.2022.965654</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm>Another institution paid the OA fee</apcterm><funders>The DIAMOND trial was funded by the Health Research Council of New Zealand (16/605) and Counties Manukau Health (269).</funders><projectreference/><lastEdited>2024-12-20T11:37:16.4950427</lastEdited><Created>2024-10-18T08:55:48.6756986</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">School of Health and Social Care - Public Health</level></path><authors><author><firstname>Mariana</firstname><surname>Muelbert</surname><order>1</order></author><author><firstname>Tanith</firstname><surname>Alexander</surname><order>2</order></author><author><firstname>Mark H.</firstname><surname>Vickers</surname><order>3</order></author><author><firstname>Jane E.</firstname><surname>Harding</surname><order>4</order></author><author><firstname>Laura</firstname><surname>Galante</surname><orcid>0000-0002-6190-7955</orcid><order>5</order></author><author><firstname>Frank H.</firstname><surname>Bloomfield</surname><order>6</order></author><author><firstname>(the DIAMOND study</firstname><surname>group)</surname><order>7</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2024-12-20T11:37:16.4950427 v2 68011 2024-10-18 Glucocorticoids in preterm human milk d1c6c22f6a863ef2050ed9768566884b 0000-0002-6190-7955 Laura Galante Laura Galante true false 2024-10-18 MEDS Background: Glucocorticoids (GCs), cortisol and cortisone, are essential regulators of many physiological responses, including immunity, stress and mammary gland function. GCs are present in human milk (HM), but whether maternal and infant factors are associated with HM GC concentration following preterm birth is unclear.Materials and methods: HM samples were collected on postnatal day 5 and 10 and at 4 months’ corrected age (4m CA) in a cohort of moderate- and late-preterm infants. GCs in HM were measured by liquid chromatography-tandem mass spectrometry. Relationships between GCs in HM and both maternal and infant characteristics were investigated using Spearman’s correlations and linear mixed models.Results: 170 mothers of 191 infants provided 354 HM samples. Cortisol concentrations in HM increased from postnatal day 5–4m CA (mean difference [MD] 0.6 ± 0.1 ng/ml, p < 0.001). Cortisone concentration did not change across lactation but was higher than cortisol throughout. Compared to no antenatal corticosteroid (ANS), a complete course of ANS was associated with lower GC concentrations in HM through to 4m CA (cortisol: MD –0.3 ± 0.1 ng/ml, p < 0.01; cortisone MD –1.8 ± 0.4 ng/ml, p < 0.001). At 4m CA, higher maternal perceived stress was negatively associated with GC concentrations in HM (cortisol adjusted beta-coefficient [aβ] –0.01 ± 0.01 ng/ml, p = 0.05; and cortisone aβ –0.1 ± 0.03 ng/ml, p = 0.01), whereas higher postpartum depression and maternal obesity were associated with lower cortisone concentrations (aβ –0.1 ± 0.04 ng/ml p < 0.05; MD [healthy versus obese] –0.1 ± 0.04 ng/ml p < 0.05, respectively). There was a weak positive correlation between GC concentrations in HM and gestational age at birth (r = 0.1, p < 0.05). Infant birth head circumference z-score was negatively associated with cortisol concentrations (aβ –0.01 ± 0.04 ng/ml, p < 0.05). At hospital discharge, fat-free mass showed a weak positive correlation with cortisol concentrations (r = 0.2, p = 0.03), while fat mass showed a weak negative correlation with cortisone concentrations (r = –0.25, p < 0.001).Conclusion: The mammary gland appears to protect the infant from cortisol through inactivation into cortisone. Maternal and infant characteristics were associated with concentration of GCs in HM, including ANS, stress and depression scores, obesity, gestational age and infant size. The effects of HM glucocorticoids on long-term health outcomes requires further research. Journal Article Frontiers in Nutrition 9 Frontiers Media SA 2296-861X 27 9 2022 2022-09-27 10.3389/fnut.2022.965654 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Another institution paid the OA fee The DIAMOND trial was funded by the Health Research Council of New Zealand (16/605) and Counties Manukau Health (269). 2024-12-20T11:37:16.4950427 2024-10-18T08:55:48.6756986 Faculty of Medicine, Health and Life Sciences School of Health and Social Care - Public Health Mariana Muelbert 1 Tanith Alexander 2 Mark H. Vickers 3 Jane E. Harding 4 Laura Galante 0000-0002-6190-7955 5 Frank H. Bloomfield 6 (the DIAMOND study group) 7
title Glucocorticoids in preterm human milk
spellingShingle Glucocorticoids in preterm human milk
Laura Galante
title_short Glucocorticoids in preterm human milk
title_full Glucocorticoids in preterm human milk
title_fullStr Glucocorticoids in preterm human milk
title_full_unstemmed Glucocorticoids in preterm human milk
title_sort Glucocorticoids in preterm human milk
author_id_str_mv d1c6c22f6a863ef2050ed9768566884b
author_id_fullname_str_mv d1c6c22f6a863ef2050ed9768566884b_***_Laura Galante
author Laura Galante
author2 Mariana Muelbert
Tanith Alexander
Mark H. Vickers
Jane E. Harding
Laura Galante
Frank H. Bloomfield
(the DIAMOND study group)
format Journal article
container_title Frontiers in Nutrition
container_volume 9
publishDate 2022
institution Swansea University
issn 2296-861X
doi_str_mv 10.3389/fnut.2022.965654
publisher Frontiers Media SA
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str School of Health and Social Care - Public Health{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}School of Health and Social Care - Public Health
document_store_str 0
active_str 0
description Background: Glucocorticoids (GCs), cortisol and cortisone, are essential regulators of many physiological responses, including immunity, stress and mammary gland function. GCs are present in human milk (HM), but whether maternal and infant factors are associated with HM GC concentration following preterm birth is unclear.Materials and methods: HM samples were collected on postnatal day 5 and 10 and at 4 months’ corrected age (4m CA) in a cohort of moderate- and late-preterm infants. GCs in HM were measured by liquid chromatography-tandem mass spectrometry. Relationships between GCs in HM and both maternal and infant characteristics were investigated using Spearman’s correlations and linear mixed models.Results: 170 mothers of 191 infants provided 354 HM samples. Cortisol concentrations in HM increased from postnatal day 5–4m CA (mean difference [MD] 0.6 ± 0.1 ng/ml, p < 0.001). Cortisone concentration did not change across lactation but was higher than cortisol throughout. Compared to no antenatal corticosteroid (ANS), a complete course of ANS was associated with lower GC concentrations in HM through to 4m CA (cortisol: MD –0.3 ± 0.1 ng/ml, p < 0.01; cortisone MD –1.8 ± 0.4 ng/ml, p < 0.001). At 4m CA, higher maternal perceived stress was negatively associated with GC concentrations in HM (cortisol adjusted beta-coefficient [aβ] –0.01 ± 0.01 ng/ml, p = 0.05; and cortisone aβ –0.1 ± 0.03 ng/ml, p = 0.01), whereas higher postpartum depression and maternal obesity were associated with lower cortisone concentrations (aβ –0.1 ± 0.04 ng/ml p < 0.05; MD [healthy versus obese] –0.1 ± 0.04 ng/ml p < 0.05, respectively). There was a weak positive correlation between GC concentrations in HM and gestational age at birth (r = 0.1, p < 0.05). Infant birth head circumference z-score was negatively associated with cortisol concentrations (aβ –0.01 ± 0.04 ng/ml, p < 0.05). At hospital discharge, fat-free mass showed a weak positive correlation with cortisol concentrations (r = 0.2, p = 0.03), while fat mass showed a weak negative correlation with cortisone concentrations (r = –0.25, p < 0.001).Conclusion: The mammary gland appears to protect the infant from cortisol through inactivation into cortisone. Maternal and infant characteristics were associated with concentration of GCs in HM, including ANS, stress and depression scores, obesity, gestational age and infant size. The effects of HM glucocorticoids on long-term health outcomes requires further research.
published_date 2022-09-27T20:48:21Z
_version_ 1822074131584122880
score 11.048302